There's a lot of scary stuff out there.

Vignette

(VIGN)

makes a great consolidation buy and they hammer it.

Genentech

(DNA)

announces some pretty good news but it isn't good enough and they crush it down 16.

Sycamore

(SCMR)

keeps getting punished for that terrific quarter.

No relief yet in sight.

We continue to like boring and hate exciting. Sure beats the New Economy/Old Economy dichotomy.

James J. Cramer is manager of a hedge fund and co-founder of TheStreet.com. At time of publication, his fund had no positions in any stocks mentioned. Cramer's fund may be long or short certain stocks in his biotech or B2B rotisserie leagues or TheStreet.com New Tech 30 index. His fund often buys and sells securities that are the subject of his columns, both before and after the columns are published, and the positions that his fund takes may change at any time. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. Cramer's writings provide insights into the dynamics of money management and are not a solicitation for transactions. While he cannot provide investment advice or recommendations, he invites you to comment on his column at

jjcletters@thestreet.com.